- Expansion Stage. Four expansion cohorts with a total of up to 120 subjects with advanced UC or RCC (up to 30 subjects in each cohort) may be enrolled to obtain additional efficacy safety, PK, and pharmacodynamic data at the recommended dose and schedule.